WARFARIN Drug Patent Profile
✉ Email this page to a colleague
When do Warfarin patents expire, and what generic alternatives are available?
Warfarin is a drug marketed by Amneal Pharms, Aurobindo Pharma Usa, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa. and is included in seventeen NDAs.
The generic ingredient in WARFARIN is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Warfarin
A generic version of WARFARIN was approved as warfarin sodium by BARR on March 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WARFARIN?
- What are the global sales for WARFARIN?
- What is Average Wholesale Price for WARFARIN?
Summary for WARFARIN
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 17 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for WARFARIN |
Drug Sales Revenues: | Drug sales revenues for WARFARIN |
DailyMed Link: | WARFARIN at DailyMed |
![WARFARIN drug patent expirations Drug patent expirations by year for WARFARIN](/p/graph/s/t/WARFARIN-patent-expirations.png)
![Drug Prices for WARFARIN](/p/graph/drug-price/WARFARIN.png)
![Drug Sales Revenue Trends for WARFARIN](/p/graph/drug-sales-revenues/WARFARIN.png)